Skip to main content
. Author manuscript; available in PMC: 2010 Dec 22.
Published in final edited form as: Transplant Proc. 1991 Dec;23(6):3005–3006.

Table 1.

Summary of Clinicopathologic Profile of Patients Prior to Conversion and Outcome After Switch to FK 506, Based on at Least 9 Months Follow-Up

Pre–FK 506 Diagnosis No. Patients Died Retransplanted Functioning Histologic Follow-Up
Biochemical Parameters of Liver Injury After Conversion
Improved No Change Worse
Acute cellular rejection 18 3 1 14 10 4 0 Improved
Chronic rejection 33 0 11* 22 13 9 0 Improved
Chronic rejection
 CPH/CAH
20 0 4 16 1 10 5 Mixed
Hepatitis§ 7 4 1 2 0 0 2 Worse
Nonspecific changes|| 18 0 0 18 0 18 0 Same
*

Seven/11 patients had >50% bile duct loss and total serum bilirubin > 15 mg/dL prior to conversion.

All but 2 patients had <50% bile duct loss and total serum bilirubin <15 mg/dL prior to conversion.

Initial cause of graft malfunction was uncertain. Difficulty in separating ongoing rejection from chronic persistent (CPH) or low-grade chronic active hepatitis (CAH) was encountered.

§

Acute and chronic active.

||

Patients were switched primarily for reasons other than graft dysfunction.

Based on examination of functioning grafts 180 days after conversion.